A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas
- PMID: 38294658
- PMCID: PMC11196359
- DOI: 10.1007/s40618-023-02287-x
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas
Abstract
Purpose: Multiple endocrine neoplasia type 1 (MEN1) is a hereditary endocrine syndrome caused by pathogenic variants in MEN1 tumor suppressor gene. Diagnosis is commonly based on clinical criteria and confirmed by genetic testing. The objective of the present study was to report on a MEN1 case characterized by multiple pancreatic glucagonomas, with particular concern on the possible predisposing genetic defects.
Methods: While conducting an extensive review of the most recent scientific evidence on the unusual glucagonoma familial forms, we analyzed the MEN1 gene in a 35-year-old female with MEN1, as well as her son and daughter, using Sanger and next-generation sequencing (NGS) approaches. We additionally explored the functional and structural consequences of the identified variant using in silico analyses.
Results: NGS did not show any known pathogenic variant in the tested regions. However, a new non-conservative variant in exon 4 of MEN1 gene was found in heterozygosity in the patient and in her daughter, resulting in an amino acid substitution from hydrophobic cysteine to hydrophilic arginine at c.703T > C, p.(Cys235Arg). This variant is absent from populations databases and was never reported in full papers: its characteristics, together with the high specificity of the patient's clinical phenotype, pointed toward a possible causative role.
Conclusion: Our findings confirm the need for careful genetic analysis of patients with MEN1 and establish a likely pathogenic role for the new p.(Cys235Arg) variant, at least in the rare subset of MEN1 associated with glucagonomas.
Keywords: Adrenal gland adenoma; Familiar; Necrolytic migratory erythema; Neuroendocrine pancreatic tumor; Next-generation sequencing; Primary hyperparathyroidism.
© 2024. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures






Similar articles
-
A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.Intern Med. 2015;54(19):2475-81. doi: 10.2169/internalmedicine.54.4886. Epub 2015 Oct 1. Intern Med. 2015. PMID: 26424307
-
Case report: Novel germline c.587delA pathogenic variant in familial multiple endocrine neoplasia type 1.Front Endocrinol (Lausanne). 2024 Sep 20;15:1467882. doi: 10.3389/fendo.2024.1467882. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39371924 Free PMC article.
-
A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.Medicine (Baltimore). 2021 Jun 25;100(25):e26382. doi: 10.1097/MD.0000000000026382. Medicine (Baltimore). 2021. PMID: 34160414 Free PMC article.
-
Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.Recent Prog Horm Res. 1999;54:397-438; discussion 438-9. Recent Prog Horm Res. 1999. PMID: 10548885 Review.
-
Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).Minerva Endocrinol. 2013 Mar;38(1):17-28. Minerva Endocrinol. 2013. PMID: 23435440 Review.
Cited by
-
Turning Points in Cross-Disciplinary Perspective of Primary Hyperparathyroidism and Pancreas Involvements: Hypercalcemia-Induced Pancreatitis, MEN1 Gene-Related Tumors, and Insulin Resistance.Int J Mol Sci. 2024 Jun 8;25(12):6349. doi: 10.3390/ijms25126349. Int J Mol Sci. 2024. PMID: 38928056 Free PMC article. Review.
-
Progress report on multiple endocrine neoplasia type 1.Fam Cancer. 2025 Jan 18;24(1):15. doi: 10.1007/s10689-025-00440-4. Fam Cancer. 2025. PMID: 39826015 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical